MAIA Biotechnology (MAIA) EPS (Basic) (2021 - 2026)
MAIA Biotechnology's (MAIA) quarterly EPS (Basic) came in at -$0.13 in Q2 2026, up 25.96% year-over-year from -$0.1 in Q2 2025, and up 7.25% quarter-over-quarter from -$0.14 in Q1 2026.
Powered by 
Analysis
MAIA Biotechnology (MAIA) EPS (Basic) (2021 - 2026) Analysis & Trends
MAIA Biotechnology (MAIA) has reported EPS (Basic) for 6 consecutive years, with -$0.13 the latest figure, recorded in Q2 2026.
- On a quarterly basis, EPS (Basic) rose 25.96% year-over-year to -$0.13 in Q2 2026; TTM through Jun 2026 was -$0.44, a 17.27% increase from a year earlier, with the FY2025 full-year figure at -$0.7, up 33.43% from the prior year.
- EPS (Basic) was -$0.13 for Q2 2026 at MAIA Biotechnology, up from -$0.14 in the prior quarter.
- Over five years, EPS (Basic) peaked at -$0.11 in Q4 2025 and troughed at -$0.5 in Q1 2022.
- A 5-year average of -$0.31 and a median of -$0.35 in 2023 frame the typical range for EPS (Basic).
- Across the five-year window, EPS (Basic) jumped 67.88% in 2024 and slumped 134.19% in 2025, its largest moves.
- Over 5 years, EPS (Basic) stood at -$0.45 in 2022, then declined by 5.57% to -$0.47 in 2023, then soared by 65.89% to -$0.16 in 2024, then gained by 29.78% to -$0.11 in 2025, then declined by 15.64% to -$0.13 in 2026.
- The last three EPS (Basic) figures came in at -$0.13 (Q2 2026), -$0.14 (Q1 2026), and -$0.11 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn | 4.40 |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn | -8.44 |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn | 4.34 |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn | 12.62 |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn | 7.70 |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn | -1.96 |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn | 1.23 |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn | 0.66 |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn | -0.40 |
| 10 | MAIA Biotechnology | 79.34 Mn | 51.74 Mn | - | -0.13 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -0.13 |
| Mar 31, 2026 | -0.14 |
| Dec 31, 2025 | -0.11 |
| Sep 30, 2025 | -0.27 |
| Jun 30, 2025 | -0.18 |
| Mar 31, 2025 | -0.16 |
| Dec 31, 2024 | -0.16 |
| Sep 30, 2024 | -0.11 |
| Jun 30, 2024 | -0.40 |
| Mar 31, 2024 | -0.46 |
| Dec 31, 2023 | -0.47 |
| Sep 30, 2023 | -0.36 |
| Jun 30, 2023 | -0.35 |
| Mar 31, 2023 | -0.38 |
| Dec 31, 2022 | -0.45 |
| Sep 30, 2022 | -0.48 |
| Jun 30, 2022 | -0.40 |
| Mar 31, 2022 | -0.50 |
| Dec 31, 2021 | -0.55 |
| Sep 30, 2021 | -1.02 |